Search
for

    Sort by

    Research 331–360 of 1000+

    1. Rash from EGFR inhibitors: Opportunities and challenges for palliation Current Oncology Reports · 2008 · 18 citations
    2. Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor Biomedicine & Pharmacotherapy · 2020 · 10 citations
    3. Epiregulin promotes hair growth via EGFR‐medicated epidermal and ErbB4‐mediated dermal stimulation Cell Proliferation · 2020 · 9 citations
    4. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines Anti-Cancer Drugs · 2023 · 7 citations
    5. Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations The American Journal of Surgical Pathology · 2021 · 4 citations
    6. Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers Annals of Dermatology · 2011 · 3 citations
    7. The urine as a diagnostic key for a homozygous EGFR mutation Portuguese Journal of Nephrology & Hypertension · 2022 · 2 citations
    8. Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation Cancer Research · 2010 · 2 citations
    9. EGFR marks a subpopulation of dermal mesenchymal cells highly expressing IGF1 which enhances hair follicle regeneration. PubMed · 2023 · 1 citations
    10. Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung 2015 · 1 citations
    11. An autosomal recessive nonsense variant in the EGFR gene induces perinatal lethality in “Blonde d'Aquitaine” calves BMC Veterinary Research · 2026
    12. Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’ Journal of the European Academy of Dermatology and Venereology · 2025
    13. 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity Journal of Investigative Dermatology · 2024
    14. 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal Journal of Investigative Dermatology · 2023
    15. 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy Journal of Investigative Dermatology · 2023
    16. Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege bioRxiv (Cold Spring Harbor Laboratory) · 2023
    17. 785 Single-cell transcriptomic profile of EGFR-deficient epidermal compartments during folliculitis 2023
    18. 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis Journal of Investigative Dermatology · 2023
    19. 308 Epidermal keratinocytes regulate bacterial immune responses and host defense through EGFR 2017
    20. EGFR: stopping stathmin to start the cycle Experimental Dermatology · 2016
    21. Effects of Fumai Paste on EGFR of Skin in Vinorelbine-induced Extravasation Injury Model Rats 2014
    22. Abstract 1219: Defective catagen entry in EGFR deficient skin precedes cutaneous inflammation Cancer Research · 2012
    23. Expression of EGF and EGFR in Developing Skin of the Goat Fetus 2010
    24. Expression Characteristics of EGF and EGFR in Developing Skin of Goat Fetus 2009
    25. Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations Frontiers in Oncology · 2026
    26. Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment Clinical and Translational Science · 2025
    27. PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors) JEADV Clinical Practice · 2025
    28. Dermatologic adverse events in EGFR-TKIs: A real-world analysis. Journal of Clinical Oncology · 2024
    29. 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege 2023
    30. Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients Dermatology practical & conceptual · 2023